Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erland Erdmann

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
Vascular Health and Risk Management|November 1, 2007
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive studyErland Erdmann, John Dormandy, Robert Wilcox, et al.
Clinical Cardiology|April 22, 2009
Magnetic resonance imaging of carcinoid heart diseaseDamian Franzen, Andree Boldt, Ute Raute-Kreinsen, et al.
Internal Medicine (Tokyo, Japan)|August 7, 2012
Pneumomediastinum and striking family history: uncommon case of Birt-Hogg-Dubé syndromeGuido Michels, Erland Erdmann, Winfried Schmidt, et al.
Annals of Internal Medicine|November 19, 2003
Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenonStephan Rosenkranz, Frank Diet, Thomas Karasch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2002
Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox"Stephan Rosenkranz, Denis Knirel, Helmut Dietrich, et al.
ALTEX|January 1, 1993
[Studies about the effects of positive inotropic and vasoactive substances]Robert H. G. Schwinger, Michael Böhm, Christian Schulz, et al.
Diabetes & Vascular Disease Research|April 13, 2010
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA studyThomas Schöndorf, Georg Lübben, Efstrathios Karagiannis, et al.
Drugs of Today (Barcelona, Spain : 1998)|January 25, 2007
Case studies: reducing risk in patients with diabetesMichel Komajda, Erland Erdmann, Issei Komuro, et al.
Diabetes Care|March 1, 2007
Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failureUta C Hoppe, Nick Freemantle, John G F Cleland, et al.
Deutsches Arzteblatt International|May 9, 2012
MRI in patients with pacemakers: overview and procedural managementHenning Bovenschulte, Klaus Schlüter-Brust, Thomas Liebig, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
Vascular Health and Risk Management|November 1, 2007
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive studyErland Erdmann, John Dormandy, Robert Wilcox, et al.
Clinical Cardiology|April 22, 2009
Magnetic resonance imaging of carcinoid heart diseaseDamian Franzen, Andree Boldt, Ute Raute-Kreinsen, et al.
Internal Medicine (Tokyo, Japan)|August 7, 2012
Pneumomediastinum and striking family history: uncommon case of Birt-Hogg-Dubé syndromeGuido Michels, Erland Erdmann, Winfried Schmidt, et al.
Annals of Internal Medicine|November 19, 2003
Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenonStephan Rosenkranz, Frank Diet, Thomas Karasch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2002
Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox"Stephan Rosenkranz, Denis Knirel, Helmut Dietrich, et al.
ALTEX|January 1, 1993
[Studies about the effects of positive inotropic and vasoactive substances]Robert H. G. Schwinger, Michael Böhm, Christian Schulz, et al.
Diabetes & Vascular Disease Research|April 13, 2010
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA studyThomas Schöndorf, Georg Lübben, Efstrathios Karagiannis, et al.
Drugs of Today (Barcelona, Spain : 1998)|January 25, 2007
Case studies: reducing risk in patients with diabetesMichel Komajda, Erland Erdmann, Issei Komuro, et al.
Diabetes Care|March 1, 2007
Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failureUta C Hoppe, Nick Freemantle, John G F Cleland, et al.
Deutsches Arzteblatt International|May 9, 2012
MRI in patients with pacemakers: overview and procedural managementHenning Bovenschulte, Klaus Schlüter-Brust, Thomas Liebig, et al.
Pageof 14